Maximilian A R Strobl

Geciteerd door

	Alles	Sinds 2020
Citaties	476	463
h-index	12	12
i10-index	14	14

200

100

150

20162017201820192020202120222023202420252 2 4 4 24 46 51 135 186 20

Openbare toegang

Alles bekijken

16 artikelen

0 artikelen

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer CenterGeverifieerd e-mailadres voor moffitt.org
Mark Robertson-TessiIntegrated Mathematical Oncology, Moffitt Cancer CenterGeverifieerd e-mailadres voor moffitt.org
Jeffrey WestIntegrated Mathematical Oncology, Moffitt Cancer CenterGeverifieerd e-mailadres voor moffitt.org
Philip MainiProfessor of Mathematical BiologyGeverifieerd e-mailadres voor maths.ox.ac.uk
Mehdi DamaghiAssistant professor at Stony Brook medicine, dept of pathology and SB cancer centerGeverifieerd e-mailadres voor stonybrookmedicine.edu
Joel S BrownMoffitt Cancer CenterGeverifieerd e-mailadres voor darwiniandynamics.org
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterGeverifieerd e-mailadres voor moffitt.org
Andriy MarusykMoffitt Cancer CenterGeverifieerd e-mailadres voor moffitt.org
Andrew KrauseDurham UniversityGeverifieerd e-mailadres voor durham.ac.uk
Liliana Ramona DemenescuDepartment of Psychiatry, Psychotherapy and Psychosomatic, Uniklinik Aachen, GermanyGeverifieerd e-mailadres voor canlab.de
Maarten De VosESAT - Stadius & Department of Development and Regeneration, KU Leuven, BelgiumGeverifieerd e-mailadres voor kuleuven.be
Michael LindemannBaden-Wuerttemberg Cooperative State UniversityGeverifieerd e-mailadres voor dhbw-loerrach.de
Heiko EnderlingProfessor, Radiation Oncology, Inst. for Data Science, MD Anderson Cancer Center, Houston, TX, USAGeverifieerd e-mailadres voor mdanderson.org
Lee Curtin, PhDSenior Bioinformatician, Precision Neurotherapeutics Innovation Program, Mayo ClinicGeverifieerd e-mailadres voor mayo.edu
Daniel NicholEvolutionary Genomics and Modelling, Institute of Cancer Research, UKGeverifieerd e-mailadres voor icr.ac.uk
Ilke TunaliEli Lilly & CompanyGeverifieerd e-mailadres voor lilly.com
Jamie DeanJunior Group Leader, University College LondonGeverifieerd e-mailadres voor ucl.ac.uk
Iman Tavassoly, MD, PhDVirginia Tech, Icahn School of Medicine at Mount SinaiGeverifieerd e-mailadres voor vt.edu
Inmaculada C. SorribesQuantitative Pharmacology and Pharmacometrics Immune/Oncology, MerckGeverifieerd e-mailadres voor merck.com
Jakob Nikolas Kather, MD, MScElse Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, GermanyGeverifieerd e-mailadres voor tu-dresden.de

Volgen

Maximilian A R Strobl

Postdoctoral Research Fellow, Cleveland Clinic, USA

Geverifieerd e-mailadres voor ccf.org - Homepage

Mathematical Oncology Evolutionary Therapy Cancer Ecology and Evolution


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer research 81 (4), 1135-1147, 2021	118	2021
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications Medicine 2 (1), 1-18, 2022	64	2022
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023	50	2023
Look me in the eye: evaluating the accuracy of smartphone-based eye tracking for potential application in autism spectrum disorder research MAR Strobl, F Lipsmeier, LR Demenescu, C Gossens, M Lindemann, ... Biomedical engineering online 18 (1), 1-12, 2019	41	2019
Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1-16, 2022	36	2022
Mix and Match: Phenotypic Coexistence as a Key Facilitator of Cancer Invasion MAR Strobl, AL Krause, M Damaghi, R Gillies, ARA Anderson, PK Maini Bulletin of Mathematical Biology 82 (1), 1-26, 2020	25	2020
Treatment of evolving cancers will require dynamic decision support MAR Strobl, J Gallaher, M Robertson-Tessi, J West, ARA Anderson Annals of Oncology 34 (10), 867-884, 2023	22	2023
On simulated annealing phase transitions in phylogeny reconstruction MAR Strobl, D Barker Molecular phylogenetics and evolution 101, 46-55, 2016	22	2016
Drug dependence in cancer is exploitable by optimally constructed treatment holidays J Maltas, ST Killarney, KR Singleton, MAR Strobl, R Washart, KC Wood, ... Nature Ecology & Evolution 8 (1), 147-162, 2024	18	2024
Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy K Gallagher, MAR Strobl, DS Park, FC Spoendlin, RA Gatenby, PK Maini, ... Cancer Research 84 (11), 1929-1941, 2024	13	2024
Combining radiomics and mathematical modeling to elucidate mechanisms of resistance to immune checkpoint blockade in non-small cell lung cancer D Saeed-Vafa, R Bravo, JA Dean, A El-Kenawi, N Mon Père, M Strobl, ... BioRxiv, 190561, 2017	13	2017
Inter-and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics J Gallaher, M Strobl, J West, R Gatenby, J Zhang, M Robertson-Tessi, ... Cancer Research, CAN-22-2558, 2023	12*	2023
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies M Robertson-Tessi, JS Brown, M Poole, M Johnson, A Marusyk, ... medRxiv, 2023.01. 18.23284628, 2023	12	2023
Antifragile therapy J West, B Desai, M Strobl, L Pierik, R Vander Velde, C Armagost, R Miles, ... bioRxiv, 2020.10. 08.331678, 2021	11	2021
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling M Strobl, A Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ... bioRxiv, 2023.03. 22.533721, 2023	9	2023
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy MAR Strobl, AL Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ... Cell Systems 15 (6), 510-525. e6, 2024	4	2024
Harnessing patient-specific response dynamics to optimize evolutionary therapies for metastatic clear cell renal cell carcinoma-Learning to adapt IC Sorribes, A Basu, R Brady, PM Enriquez-Navas, X Feng, JN Kather, ... bioRxiv, 563130, 2019	3	2019
The balance between intrinsic and ecological fitness defines new regimes in eco-evolutionary population dynamics RJ Barker-Clarke, JM Gray, MAR Strobl, J Maltas, DS Tadele, ... bioRxiv, 2023.03. 15.532871, 2023	1*	2023
Learning to Adapt-Deep Reinforcement Learning in Treatment-Resistant Prostate Cancer K Gallagher, M Strobl, R Gatenby, P Maini, A Anderson bioRxiv, 2023.04. 28.538766, 2023	1	2023
Connecting the Microenvironmental Niche to Treatment Response in Ovarian Cancer M Strobl, M Wicker, V Adhikarla, WA Shockey, E Lakatos, P Pooladvand, ... BioRxiv, 452052, 2018	1	2018

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs